Geraldine P, Sneha B Brijit, Elanchezhian R, Ramesh E, Kalavathy C M, Kaliamurthy J, Thomas P A
Department of Animal Science, Bharathidasan University, Tiruchirapalli, India.
Exp Eye Res. 2006 Dec;83(6):1340-9. doi: 10.1016/j.exer.2006.07.009. Epub 2006 Sep 8.
Several studies have suggested that antioxidants retard the process of cataractogenesis by scavenging free oxygen radicals. The present study sought to assess the efficacy of the antioxidant acetyl-L-carnitine (ALCAR) in preventing selenite-induced cataractogenesis in an experimental setting. The first, in vitro phase of the study was performed on lenses from Wistar rats incubated for 24 h at 37 degrees C in Dulbecco's Modified Eagle Medium (DMEM) alone (control, Group I), or in DMEM containing 100 microM of selenite (Group II) or in DMEM containing 100 microM of selenite and 200 microM/ml ALCAR added at the same time as selenite (Group IIIa) or 30 min, 1 h or 2 h later (Groups IIIb, IIIc and IIId, respectively). Gross morphological examination of these lenses revealed dense opacification (cataract formation) in Group II, minimal opacification in some Group IIIa lenses and no opacification in Group I. The mean activities of the antioxidant enzymes catalase and glutathione peroxidase were significantly lower in Group II than in Group I or Group IIIa lenses, while malondialdehyde concentration (an indicator of lipid peroxidation) was significantly higher in Group II lenses than that in Group I or Group IIIa lenses. The second, in vivo phase of the study revealed dense opacification (cataract formation) in 100% of Wistar rat pups receiving subcutaneous sodium selenite alone (19 microM/kg body weight) but in only 37.5% of those receiving subcutaneous selenite and intraperitoneal ALCAR. These data suggest that ALCAR is able to significantly retard experimental selenite-induced cataractogenesis.
多项研究表明,抗氧化剂可通过清除游离氧自由基来延缓白内障的形成过程。本研究旨在评估抗氧化剂乙酰左旋肉碱(ALCAR)在实验环境中预防亚硒酸盐诱导的白内障形成的效果。该研究的第一阶段为体外实验,使用Wistar大鼠的晶状体,将其在37摄氏度下于杜氏改良伊格尔培养基(DMEM)中单独孵育24小时(对照组,第一组),或在含有100微摩尔亚硒酸盐的DMEM中孵育(第二组),或在含有100微摩尔亚硒酸盐且与亚硒酸盐同时添加200微摩尔/毫升ALCAR的DMEM中孵育(第三组a),或在添加亚硒酸盐30分钟、1小时或2小时后添加ALCAR(分别为第三组b、第三组c和第三组d)。对这些晶状体的大体形态学检查显示,第二组出现致密浑浊(白内障形成),第三组a的一些晶状体有轻微浑浊,第一组无浑浊。抗氧化酶过氧化氢酶和谷胱甘肽过氧化物酶的平均活性在第二组中显著低于第一组或第三组a的晶状体,而丙二醛浓度(脂质过氧化的指标)在第二组晶状体中显著高于第一组或第三组a的晶状体。该研究的第二阶段为体内实验,结果显示,仅接受皮下注射亚硒酸钠(19微摩尔/千克体重)的Wistar大鼠幼崽中100%出现致密浑浊(白内障形成),而接受皮下注射亚硒酸盐和腹腔注射ALCAR的幼崽中只有37.5%出现白内障。这些数据表明,ALCAR能够显著延缓实验性亚硒酸盐诱导的白内障形成。